| Literature DB >> 18423000 |
Sven Martin Jørgensen1, Sergey Afanasyev, Aleksei Krasnov.
Abstract
BACKGROUND: Infectious salmon anemia virus (ISAV) causes a multisystemic disease responsible for severe losses in salmon aquaculture. Better understanding of factors that explain variations in resistance between individuals and families is essential for development of strategies for disease control. To approach this, we compared global gene expression using microarrays in fish dying early and late in the time course following infection from a highly pathogenic ISAV.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18423000 PMCID: PMC2387173 DOI: 10.1186/1471-2164-9-179
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Experimental ISAV challenge trial. Mortality curves of the standardised ISAV cohabitation challenge among i.p.-injected carriers ('shedder', grey curve) and cohabitants ('cohab', black curve).
Figure 2Viral loads analysed by real-time qPCR. Viral RNA levels of segment 6 in liver, gill, heart and spleen of four fish from EM, IM and LM stages. Levels are given as cycle threshold (CT) values (left Y-axis) and log10 number of viral particles (right Y-axis) based on a standard curve of CT against titrated in vitro infected (Glesvaer 2/90 isolate) ASK (Atlantic salmon kidney) cells.
Figure 3EM-induced genes with similar expression changes across tissues. Data are log-ER (Expression Ratio). Microarray analyses were conducted on individual liver samples (the group means are shown, n = 6; underlined values mean significantly different groups, p < 0.05) and in pooled samples (n = 6 per tissue) of liver, gill, heart and spleen (the average values of two slides are shown). Up- and down-regulated genes are highlighted with orange and green scales, as shown below the figure. NS means not significant (p < 0.01, t-test, 6 spot replicates per gene).
Figure 4Real-time qPCR analysis of early induced genes in heart from EM and LM. Selected genes from microarray were; galectin-3 binding protein (GAL3BP), galectin 1-like (GAL1), tripartite motif protein/ring finger protein (TRIM/RING), tyrosine-protein kinase FRK (FRK), signal transducer/activator of transcription 1 (STAT1), CCAAT/enhancer binding protein beta (C/EBPb), beta-2 microglobulin-1 BA1 (B2M). Data are mean relative expression ratios ± SE of 4 infected individuals relative to 4 controls (C) per stage, normalized against 18S rRNA levels and adjusted for PCR efficiency. Bars with different letters are significantly different (p < 0.05).
Figure 5Immunoglobulin-related transcripts induced in LM. Microarray expression (mean log(ER) ± SE) in gill, heart, liver and spleen (6 individuals pooled per tissue) of 11 immunoglobulin-related clones designated by the Unigene clusters and most similar mammalian proteins: Omy.9391 (similar to Ig-kappa chain V-III region VG and Ig-kappa chain C region), Omy.15640 (similar to Ig-gamma-2 chain C region and Ig-mu chain C region membrane-bound), Ssa.78 (similar to Ig heavy chain V-III region HIL), Ssa.709 (similar to Ig-kappa chain V-I region WEA and to Ig-kappa chain V-IV region B17-2), Omy.416 (similar to Ig-kappa chain V-IV region JI), Omy.23312 (similar to Ig-kappa chain V-IV region B17-1), Omy.30091 (similar to Ig-kappa chain V-IV region Len) and Omy.11287 (similar to Ig-mu heavy chain disease protein). Asteriks indicates significantly different groups (p < 0.0001).
Figure 6Real-time qPCR analyses of genes related to adaptive immunity from spleen at all stages. Selected genes were; heavy chains of immunoglobulin zeta (IgZ) and immunoglobulin mju (IgM), T cell coreceptors CD4 (CD4) and CD8alpha (CD8a), TH2 cytokine transforming growth factor beta (TGFb), TH1 cytokine interferon gamma (IFNg). Data are mean relative expression ratios ± SE of 6 infected individuals relative to 6 controls (C) per stage, normalized against 18S rRNA levels and adjusted for PCR efficiency. IFN-γ expression is shown with own Y-axis for easier comparison between genes. Bars with different letters are significantly different (p < 0.05).
Microarray expression of genes encoding chaperones in liver. The data are mean log(ER) ± SE.
| Genes | EM | LM | LM-EM1 |
| Heat shock protein HSP 90-beta | 0,97 ± 0,22 | -0,15 ± 0,13 | -1,13 |
| Heat shock cognate 70 kDa | 0,35 ± 0,19 | -0,70 ± 0,07 | -1,05 |
| Heat shock cognate 71 kDa | 0,42 ± 0,21 | -0,60 ± 0,10 | -1,02 |
| Heat shock 70 kDa-8 | 0,01 ± 0,15 | -0,89 ± 0,09 | -0,90 |
| Heat shock protein 75 kDa-2 | -0,87 ± 0,08 | -1,36 ± 0,10 | -0,48 |
| Heat shock factor 2-2 | -0,78 ± 0,10 | -1,28 ± 0,04 | -0,50 |
| DnaJ homolog subfamily B member 11 | 0,98 ± 0,25 | -0,02 ± 0,27 | -1,00 |
| DnaJ homolog subfamily C member 9 | -1,02 ± 0,16 | -1,69 ± 0,13 | -0,68 |
| DnaJ homolog subfamily A member 2 | 0,24 ± 0,11 | -0,40 ± 0,09 | -0,64 |
| T-complex protein 1, subunit 5 | 0,86 ± 0,12 | 0,27 ± 0,12 | -0,59 |
| T-complex protein 1, gamma subunit | -0,53 ± 0,12 | -1,02 ± 0,10 | -0,49 |
1Difference of mean log(ER) between two groups. All mean log(ER) were significantly lower in LM (p < 0.001, t-test, n = 12).
Hepatic microarray expression of genes implicated in metabolism of lipids and steroids. The data are mean log(ER) ± SE.
| Genes | EM | LM | LM-EM |
| CCAAT/enhancer binding protein delta1 | -0,26 ± 0,19 | -1,07 ± 0,20 | -0.81 |
| Leukotriene B4 receptor1,2 | -1,17 ± 0,11 | -1,85 ± 0,16 | -0.68 |
| Carboxylesterase HU1a1 | -0,48 ± 0,11 | -1,42 ± 0,37 | -0.94 |
| Delta-6 fatty acid desaturase | -1,16 ± 0,11 | -1,04 ± 0,19 | 0.12 |
| Cytochrome P450 2K41,2 | -0,36 ± 0,15 | -1,19 ± 0,16 | -0.83 |
| Cytochrome P450 2F11,2 | -1,09 ± 0,13 | -1,85 ± 0,19 | -0.76 |
| 3-oxo-5-beta-steroid 4-dehydrogenase | -1,62 ± 0,43 | -2,07 ± 0,50 | -0.45 |
| Estradiol 17 beta-dehydrogenase | -0,71 ± 0,13 | -0,93 ± 0,21 | -0.22 |
| Prostaglandine D synthase | -1,09 ± 0,23 | -0,92 ± 0,27 | 0.17 |
| Progesterone receptor component 21 | -0,67 ± 0,16 | -1,15 ± 0,17 | -0.48 |
| Estrogen-responsive B box protein1 | -0,45 ± 0,10 | -1,11 ± 0,15 | -0.66 |
| D-3-phosphoglycerate dehydrogenase1 | -0,86 ± 0,12 | -1,23 ± 0,06 | -0.37 |
| Sodium/bile acid cotransporter1 | -0,94 ± 0,07 | -1,30 ± 0,08 | -0.36 |
| All-trans-13,14-dihydroretinol saturase2 | -0,98 ± 0,16 | -1,27 ± 0,09 | -0.29 |
| 5-lipoxygenase activating protein1,2 | 0,34 ± 0,14 | 1,55 ± 0,32 | 1.21 |
| Annexin A11,2 | -0,16 ± 0,09 | 1,59 ± 0,55 | 1.75 |
1Significant difference between groups (p < 0.05, t-test, n = 12). 2Involved in metabolism of eicosanoids
Real-time qPCR primers used in the study
| ISAV segment 6 a | 5-AGGCCAAAAACGGAAATGGA-3 | |
| 5-CCGTCAGTGCAGTCATTGGTT-3 | ||
| 18S rRNA b | 5-GCCCTATCAACTTTCGATGGTAC-3 | |
| 5-TTTGGATGTGGTAGCCGTTTCTC-3 | ||
| Galectin-3 binding prot c | 5-CCAGACCAACAGTGTTCACTTCAGC-3 | |
| 5-ACGTGAAAGACATACCTGCCCTCAC-3 | ||
| Galectin-like 1 c | 5-CAGCAACCCTTCTTCAATCCGAGA-3 | |
| 5-TCTCCCTGTCACAGTGATGGTCTTC-3 | ||
| Tripartite motif/ring finger protein c | 5-TGTTCTGTTGCTCCGTCTGTCTGGA-3 | |
| 5-TTCAGCCAGCACGGTGTTTCTCTTC-3 | ||
| Tyr-protein kinase FRK c | 5-TAGACATGGCACCATGGACCCTC-3 | |
| 5-GGGTTCTTCAGTGCAGACAGCCA-3 | ||
| STAT1 c | 5-GAACATGGAGGAGTCCAATGGAAGC-3 | |
| 5-GGACCCTCATTTGATCTGTTGCCT-3 | ||
| CCAAT/enhancer binding protein beta c | 5-TACGTCCTGGGCTATCCTGAACTGC-3 | |
| 5-CCAGACGAACCGTTGTTGTCCA-3 | ||
| Beta-2-microglobulin c | 5-TCGTTGTACTTGTGCTCATTTACAGC-3 | |
| 5-CAGGGTATTCTTATCTCCAAAGTTGC-3 | ||
| IgM heavy chain (CH) d | 5-ATACGGTGACCCTGACTTGCTACGT-3 | |
| 5-TTCTCTCCACCGGCTCATCATCA-3 | ||
| IgZ CH-like d | 5-AGCACCAGGGACAAACCACCAT-3 | |
| 5-TTCACACTCGGTGGGTTCAGAGTC-3 | ||
| IgD CH d | 5-TCTTCAGGAGCTGAGGACAGATGGA-3 | |
| 5-AAACCCATCCACCTTCCAGCTGA-3 | ||
| CD4 d | 5-TGCATTGTTCCTCTCTTCCACAGC-3 | |
| 5-CCGTCCCAAGGTACCATAGTACCAA-3 | ||
| TGF-beta d | 5-AATCGGAGAGTTGCTGTGTGCGA-3 | |
| 5-GGGTTGTGGTGCTTATACAGAGCCA-3 | ||
| CD8-alpha d | 5-CGTCTACAGCTGTGCATCAATCAA-3 | |
| 5-GGCTGTGGTCATTGGTGTAGTC-3 | ||
| Interferon-gamma d | 5-TTCAGGAGACCCAGAAACACTAC-3 | |
| 5-TAATGAACTCGGACAGAGCCTTC-3 | ||
| GRB2-related adaptor protein 2 e | 5-TGACTTTACTGCCACTGCTGAGGAC-3 | |
| 5-CAGTCATCATTGGTGCCCAAGATC-3 | ||
| Annexin A1-1 e | 5-CTCCAGGAAATTGAACACCGCGA-3 | |
| 5-AAGGCTGCGATGAAGGACATGGT-3 | ||
| 5-lipoxygenase activating protein e | 5-TCTGAGTCATGCTGTCCGTAGTGGT-3 | |
| 5-CCTCCCTCTCTACCTTCGTTGCAAA-3 | ||
| Regulator of G-protein signaling 1-1 e | 5-GACTCCTAACCTCCAATGCTTCGAC-3 | |
| 5-CGAATCTCTCTCCATCAGCCCATA-3 | ||
| Cytochrome P450 2K4-1 e | 5-TTCACCCTCCACCCTTCACCTC-3 | |
| 5-ATCTCAGACCCGGCTCACAGCA-3 | ||
| Galectin-9 e | 5-TCGCTGATTGTGAATGGTGCTCAC-3 | |
| 5-CAGGGTTGGAGAAGGCAATGGATT-3 | ||
| Heat shock protein HSP 90-beta-2e | 5-GAACCTCTGCAAGCTCATGAAGGA-3 | |
| 5-ACCAGCCTGTTTGACACAGTCACCT-3 | ||
| Cathepsin S e | 5-CGAAGGGAGGTCTGGGAGAGGAAT-3 | |
| 5-GCCCAGGTCATAGGTGTGCATGTC-3 |
a Viral RNA quantification. b Reference gene. c Microarray confirmation and EM-induced genes, Fig. 4. d Adaptive immune responses all stages, Fig. 6. e Development of class prediction, Fig. 7.
Figure 7Class prediction based on qPCR analyses of eight genes in liver. The training and test sets were analyzed in two independent experiments indicated with different colours. The predictor function was constructed by linear discriminant analysis of the training group and verified using the test group. Numbers of individuals: 1–9 – EM, 10–23 – IM, 24–35 – LM and 36–45 – control.